Clinical Trial Update: A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating long-term safety, tolerability, and effect on disease course for Relapsing Multiple Sclerosis; study terminated with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Relapsing Multiple Sclerosis | Phase 3 | Status: TERMINATED | Results posted: 2019-01-08